PubRank

Lorenzo Alberio

Author PubWeight™ 26.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003 3.88
2 Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 2002 1.93
3 Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002 1.63
4 Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 2008 1.50
5 The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Blood 2014 1.38
6 D-dimers predict stroke subtype when assessed early. Cerebrovasc Dis 2009 0.92
7 von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience. Semin Hematol 2004 0.92
8 Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes. BMC Nephrol 2009 0.92
9 Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment. Pediatr Emerg Care 2010 0.88
10 Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients. Blood 2008 0.86
11 Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems. Thromb Haemost 2004 0.85
12 Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis. Thromb Haemost 2007 0.84
13 Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency. Semin Hematol 2004 0.84
14 Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test? Thromb Haemost 2009 0.83
15 Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland. Ann Hematol 2008 0.83
16 Monitoring thrombin generation by electrochemistry: development of an amperometric biosensor screening test for plasma and whole blood. Clin Chem 2009 0.81
17 Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura. Haematologica 2004 0.80
18 Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients. Haematologica 2011 0.80
19 Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort. Hum Mutat 2015 0.79
20 Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study. Thromb J 2013 0.77
21 Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial. Trials 2009 0.77
22 Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation. Thromb Haemost 2011 0.77
23 Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis. Thromb Haemost 2009 0.76
24 On the dosing of lepirudin. Br J Clin Pharmacol 2011 0.75
25 Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review. Thromb Haemost 2016 0.75
26 Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis. Cytometry B Clin Cytom 2014 0.75
27 Formaldehyde-fixation of platelets for flow cytometric measurement of phosphatidylserine exposure is feasible. Cytometry A 2014 0.75
28 [Pancytopenia, Hemolytic Anemia and Schizocytes: a Pragmatic Approach]. Praxis (Bern 1994) 2015 0.75
29 Quantitative assessment of elevated D-dimers. Int J Hematol 2007 0.75
30 Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. J Perinat Med 2011 0.75
31 Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients. Swiss Med Wkly 2011 0.75
32 Thrombotic thrombocytopenic purpura. Hematol J 2004 0.75
33 Stability of low molecular weight heparin anti-factor Xa activity in citrated whole blood and plasma. Br J Haematol 2011 0.75